666P Updated efficacy and safety data of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) solid tumours

S Lu, F.G.M De Braud + Show 13 more

Open Access

https://doi.org/10.1016/j.annonc.2023.09.1852

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Publication Date: Oct 1, 2023

Affiliation: Shanghai Jiao Tong University, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Zhejiang Cancer Hospital, Fudan University Shanghai Cancer Center, Third Affiliated Hospital of Harbin Medical University, Sungkyunkwan University, Centre Léon Bérard, Massachusetts General Hospital, Hospital Universitario 12 De Octubre, Roche (Canada), Roche (Switzerland), Genentech, Huazhong University of Science and Technology

#Entrectinib In Patients #Fusion-positive Solid Tumours + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

666P Updated efficacy and safety data of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) solid tumours

Full Text

Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export